Celaid Therapeutics
Improving QOL of patients with blood diseases.
Biotechnology·0 Followers
Overview
Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene e...See more
Website
https://celaidtx.com/en/Industry
Biotechnology
Company size
16 employees
Headquarters
Bunkyo-ku, Tokyo
Founded
2020
Upgrade to view team
View current team members and their roles
Access founders information
Request warm introductions
Funding Rounds (1)
$2.6M • Series B
Announced on 10/5/2026
Approximately USD2.6 million second close; USD22.1 million is the cumulative Series B total.
Open Positions(0)
No open jobs posted for this organization yet.
Company Updates
No updates available yet.